Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for RALOXIFENE HYDROCHLORIDE
- XCHT for Irinotecan-Induced Gut Toxicities (Randomized Controlled Trial)
- Capecitabine Induced Hand And Foot Syndrome
- Effect of Raloxifene Plus Cholecalciferol and Cholecalciferol Alone on the Bone Mineral Density in Postmenopausal Women With Osteopenia: an 1-year Randomized Controlled Trial
- Multicenter Double Blind, Parallel-group Phase 2/3 Trial, to Study Raloxifene in Adult COVID-19 Patients.
- XCHT for Irinotecan-Induced Gut Toxicities (Run-in Study)
- Bazedoxifene -Treatment for Women With Schizophrenia
- Clinical Trial to Evaluate the Efficacy of a Dyslipidemic Therapy in Mexican Population
- Comparative Antiresorptive Efficacy Discontinuation of Denosumab
- Adjunctive Selective Estrogen Receptor Modulators on Negative and Cognitive Symptoms of Schizophrenia in Women
- Clinical Studies by Using Alphacait to Screen Drugs for Advanced Solid Tumor
- Bicalutamide and Raloxifene Hydrochloride in Treating Patients With Prostate Cancer Undergoing Surgery
- Raloxifene Augmentation in Patients With a Schizophrenia Spectrum Disorder
- DP-R213 Phase 1 Pharmacokinetics Study
- Osteoporosis Treatment in Post-menopausal Women
- Clinical Trial on the Efficacy of Raloxifene on Disease Activity in Rheumatoid Arthritis
- The Effects of Seasonal Changes in Osteoporosis Treatment
- DP-R213 Pharmacokinetics Study
- A Drug-drug Interaction Study of DP-R213
- Tamoxifen in Patients With Oesophageal Cancer
- Longjohn Amgen Study - Effect of Denosumab...
- Selective Estrogen Receptor Modulators for Women of Child-bearing Age With Schizophrenia
- The Efficacy of Denosumab in Active Crohn's Disease
- Therapeutic Equivalence Between Branded and Generic WARFArin Tablets in Brazil
- Efficacy Study of Raloxifene to Induce Ovulation in Polycystic Ovarian Syndrome
- Raloxifene as an Adjuvant Treatment of the Negative Symptoms of Schizophrenia in Post-menopausal Women
- Clinical Study of Raloxifene and Strontium Ranelate in Postmenopausal Osteoporosis
- Combined Administration of Teripapartide and Antiresorptive Agents in Postmenopausal Osteoporosis
- Selective Estrogen Receptor Modulators (SERMs) - A Potential Treatment for Psychotic Symptoms of Schizophrenia in Men?
- Fenretinide in Healthy Young Women at Genetic and Familial Risk
- Bazedoxifene Post Approval Safety Study (PASS) in the European Union (EU)
- Breast Cancer Chemoprevention by SOM230, an IGF-I Action Inhibitor
- Raloxifene in Treatment of Schizophrenia and Schizoaffective Disorder
- Enhancing Osteoporosis Therapy: Can We Open the Anabolic Window?
- Observational Study of Incidence Rates of Esophageal Cancer in Women Taking Medications for the Prevention or Treatment of Osteoporosis (MK-0217A-352)
- Bicalutamide and Raloxifene in Treating Patients With Metastatic or Hormone-Refractory Prostate Cancer
- Double Blind, Placebo-controlled Study of Raloxifene for Negative Symptoms of Schizophrenia in Postmenopausal Women
- Observational Study Analyzing RNA Expression Of Endometrial Biopsy Samples From Placebo, Bazedoxifene/Conjugated Estrogens And Raloxifene
- Risedronate vs Raloxifene in Hormone Replacement Therapy Discontinuation
- Study Evaluating Changes In Mammographic Breast Density
- Back Pain in Patients With Severe Osteoporosis
- Nutritional Supplements and Hormonal Manipulations for Breast Cancer Prevention
- Tamoxifen for Progressive Transitional Cell Carcinoma Following Previous Chemotherapy Treatment
- Pregabalin in Treating Women With Hot Flashes
- Cognition in the Study of Tamoxifen and Raloxifene
- Study Evaluating Safety and Efficacy of Bazedoxifene/Conjugated Estrogens Combinations in Postmenopausal Women
- Comparison of Raloxifene Hydrochloride and Placebo in the Treatment of Postmenopausal Women With Osteoporosis
- Evaluating the Roles of Estrogen and Progesterone in Heart Metabolism
- Long Term Effects of Raloxifene Treatment on Bone Quality
- Carotid Artery Intima-Media Thickness Following Exposure to Raloxifene or Placebo
- Study Evaluating TSE-424/Placebo/Raloxifene in Preventing Osteoporosis in Postmenopausal Women
- Effects of Zoledronic Acid and Raloxifene on Bone Turnover Markers in Postmenopausal Women With Low Bone Mineral Density
- Comparison of Tibolone and Raloxifene on Bone Mineral Density in Osteopenic Postmenopausal Women (P06090)
- Induction of Ovulation With Raloxifene or Clomiphene Citrate in Polycystic Ovarian Syndrome
- A Comparison Study With Alendronate and Raloxifene in Postmenopausal Women With Osteoporosis (0217-189)
- Study Comparing Arzoxifene With Raloxifene in Women After Menopause With Osteoporosis
- Raloxifene for Prevention of Bone Loss in Postmenopausal Patients Receiving Chronic Corticosteroid Therapy
- Raloxifene for Women With Alzheimer's Disease
- Selective Estrogen Receptor Modulators - A Potential Treatment for Psychotic Symptoms of Schizophrenia
- Study of Hot Flashes and Night Sweats in Postmenopausal Women Receiving Combination Raloxifene and Oral Estrogen
- 3-year Study of Menostar Versus Evista to Prevent Osteoporosis in Post-menopausal Women
- The Use of Selective Estrogen Receptor Modulators in the Treatment of Schizophrenia- a Pilot Study
- Study Evaluating Bazedoxifene Acetate In Osteoporosis In Postmenopausal Women
- Combined Estrogen Blockade of the Breast With Exemestane and Raloxifene in Postmenopausal Women With a History of Breast Cancer Who Have No Clinical Evidence of Disease
- 2-Year Therapy With Teriparatide vs 1-yr Therapy Followed by 1-Year of Raloxifene or Calcium/Vit D in Severe Postmenopausal Osteoporosis
- Raloxifene Use for The Heart
- Comparison of Raloxifene and Lasofoxifene - A Randomized, Blinded Study of These Drugs and Placebo on Bone Loss
- AFTER: Altering Fat Through Estrogen and Raloxifene
- Estrogen Alternatives Study
- Effects of Teriparatide in Postmenopausal Women With Osteoporosis
- Study Comparing Lapatinib (GW572016) And Letrozole Versus Letrozole In Subjects With Advanced Or Metastatic Breast Cancer
- Cognitive and Neurophysiological Effects of Raloxifene in Alzheimer's Disease
- Vitamin K and Bone Turnover in Postmenopausal Women
- Combined Use of Teriparatide and Raloxifene in Postmenopausal Women With Osteoporosis
- Comparison of Blood Levels of Two Formulations of the Selective Hormone Receptor Modulator CDB-2914
- EVA: Evista Alendronate Comparison
- Sequential Use of Teriparatide and Raloxifene HCl in the Treatment of Postmenopausal Women With Osteoporosis
- Raloxifene and Goserelin in Preventing Breast Cancer in Women With a Family History of Breast Cancer
- Raloxifene With or Without Exercise Compared With Exercise Alone in Women Who Have Been Previously Treated for Breast Cancer
- Medroxyprogesterone Compared With Venlafaxine in Treating Hot Flashes in Women
- Raloxifene and Rimostil for Perimenopause-Related Depression
- Raloxifene in Preventing Breast Cancer in Premenopausal Women
- Use of the Synthetic Hormone CDB-2914 in Treating Symptoms of Menopause
- Parathyroid Hormone (PTH) With Alendronate for Osteoporosis
- Raloxifene in Treating Patients With Persistent or Recurrent Endometrial Cancer
- Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
- The Safety and Effectiveness of Surgery With or Without Raloxifene for the Treatment of Pelvic Pain Caused by Endometriosis
Clinical trials list
click for details